BDBM703767 N-[2-ethyl-4-oxo-3- [1-[2-(2H-tetrazol- 5-yl)phenyl]-4- piperidyl]methyl]- quinazolin-6-yl]-N- (3-pyridylmethyl)- thiophene-2-carbox- amide::US20240368133, Compound A-244
SMILES CCc1nc2ccc(N(Cc3cccnc3)C(=O)c3cccs3)cc2c(=O)n1CC1CCN(c2ccccc2-c2nn[nH]n2)CC1
InChI Key InChIKey=WFZCSDITNSGCIN-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 703767
TargetType-2 angiotensin II receptor/Low affinity immunoglobulin epsilon Fc receptor(Human)
Confo Therapeutics
US Patent
Confo Therapeutics
US Patent
Affinity DataIC50: 104nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair
Affinity DataIC50: 6.62E+3nMAssay Description:All synthesized ligands were evaluated in a radioligand assay by displacing 125I-[Sar1, Ile8]-Angiotensin II (Perkin Elmer, NEX248050UC) from human A...More data for this Ligand-Target Pair